Bionano Genomics announced the hiring of Alex Hastie, Ph.D., as Chief Scientific Officer. Dr. Hastie previously spent 14 years at Bionano, playing a foundational role in the development of the company's optical genome mapping (OGM) technology. The appointment is effective July 20, 2026. Dr. Hastie will lead global scientific strategy, innovation, and research initiatives.